Refocusing Research on Sexually Transmitted Infections

J Infect Dis. 2020 Oct 1;222(9):1432-1434. doi: 10.1093/infdis/jiz442.

Abstract

This article highlights biomedical research goals for the development of critical tools, including innovative diagnostics, safe and effective vaccines, and new and improved therapeutics, necessary to achieve an end to the global epidemic of sexually transmitted infections. The incidence of sexually transmitted infections (STIs), including gonorrhea, syphilis, chlamydia, and trichomoniasis, is increasing by over 1 million new cases daily and represents a global public health crisis. There is an alarming increase of gonorrhea and syphilis among men who have sex with men and bisexual men, 2 key populations also at high risk for human immunodeficiency virus. A refocused, dedicated, and intensive biomedical research program is needed targeting development of innovative diagnostics, safe and effective vaccines, and new and improved therapeutics. This article highlights biomedical research goals providing critical tools necessary to achieve an end to the global STIs epidemic.

Keywords: refocusing biomedical research; sexually transmitted infections.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Biomedical Research* / methods
  • Humans
  • Sexually Transmitted Diseases / diagnosis*
  • Sexually Transmitted Diseases / drug therapy
  • Sexually Transmitted Diseases / epidemiology
  • Sexually Transmitted Diseases / prevention & control
  • Vaccines / therapeutic use

Substances

  • Anti-Infective Agents
  • Vaccines